Chemical inhibitors of TXNDC14 include a diverse array of compounds that interfere with the protein's function by various mechanisms. Ebselen acts as a mimic of glutathione peroxidase, an enzyme that reduces peroxide, which in turn can alter the redox state of the cysteine residues at the active site of TXNDC14. Such alteration can result in the disruption of TXNDC14's activity, as its function is contingent upon maintaining specific redox conditions. Similarly, Auranofin targets TXNDC14 by binding to its thioredoxin-like domains, an action that misfolds the protein through the gold(I)-phosphine moiety, leading to an inhibition of its normal function. Bacitracin, on the other hand, inhibits the protein indirectly by chelating metal ions, which are crucial for the enzymatic activity of proteins like TXNDC14 that are involved in folding mechanisms.
Further, Oltipraz modifies the cellular redox environment, which can interfere with the redox-dependent functions of TXNDC14. Disulfiram achieves inhibition by binding irreversibly to thiol groups in the active site of TXNDC14, obstructing its disulfide isomerase activity essential for catalyzing the rearrangement of disulfide bonds in substrate proteins. RSL3, by inactivating GPX4, disrupts the balance of redox homeostasis, which could impinge upon the function of redox-sensitive proteins like TXNDC14. PX-12 directly modifies TXNDC14's cysteine residues covalently, thus inhibiting its enzymatic activity. Triphenylphosphine and Ellman's Reagent both act on the thiols within TXNDC14, with the former binding to and potentially reducing disulfide bonds, and the latter forming mixed disulfides with free thiols, consequently obstructing the protein's catalytic activity. Primaquine generates reactive oxygen species upon its metabolism, which can oxidize thiols in TXNDC14 leading to the impairment of its function. Lastly, Menadione engages in redox cycling to produce reactive oxygen species, which can disrupt the redox-sensitive sites within TXNDC14, compromising its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ebselen | 60940-34-3 | sc-200740B sc-200740 sc-200740A | 1 mg 25 mg 100 mg | $32.00 $133.00 $449.00 | 5 | |
Ebselen inhibits TXNDC14 by mimicking glutathione peroxidase activity, reducing disulfide bonds in proteins, and potentially altering the redox state of TXNDC14's active site cysteines. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $150.00 $210.00 $1899.00 | 39 | |
Auranofin inhibits TXNDC14 by binding to the protein's thioredoxin-like domains, disrupting its proper folding and function through its gold(I)-phosphine moiety. | ||||||
Bacitracin | 1405-87-4 | sc-252399 | 5 g | $87.00 | 1 | |
Bacitracin inhibits TXNDC14 by chelating metal ions necessary for the proper function of the protein's folding machinery, indirectly hampering its activity. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Oltipraz inhibits TXNDC14 through its ability to modify the cellular redox environment, which can interfere with the redox-dependent functions of TXNDC14. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram inhibits TXNDC14 by irreversibly modifying thiol groups in the active site, impeding its protein disulfide isomerase activity. | ||||||
RSL3 | 1219810-16-8 | sc-507385 | 10 mg | $250.00 | ||
RSL3 inhibits TXNDC14 by inactivating glutathione peroxidase 4 (GPX4), which in turn disrupts the redox homeostasis in the cell and could impact TXNDC14 function that relies on a reducing environment. | ||||||
PX 12 | 141400-58-0 | sc-358518 sc-358518A | 10 mg 50 mg | $130.00 $495.00 | 9 | |
PX-12 inhibits TXNDC14 by covalently modifying the protein's active site cysteine residues, thereby inhibiting its enzymatic activity. | ||||||
5,5′-Dithio-bis-(2-nitrobenzoic Acid) | 69-78-3 | sc-359842 | 5 g | $78.00 | 3 | |
5,5′-Dithio-bis-(2-nitrobenzoic Acid), also known as Ellman's Reagent, inhibits TXNDC14 by reacting with free thiols in the protein, forming mixed disulfides and thus blocking its thiol-mediated catalytic activity. | ||||||
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline | 90-34-6 | sc-483239 | 1 g | $360.00 | 1 | |
Primaquine inhibits TXNDC14 by producing reactive oxygen species upon metabolism, which can oxidize thiols and consequently impair the function of thiol-dependent proteins like TXNDC14. | ||||||
Vitamin K3 | 58-27-5 | sc-205990B sc-205990 sc-205990A sc-205990C sc-205990D | 5 g 10 g 25 g 100 g 500 g | $25.00 $35.00 $46.00 $133.00 $446.00 | 3 | |
Menadione inhibits TXNDC14 by redox cycling within cells, generating reactive oxygen species that can disrupt the redox-sensitive active site of the protein. | ||||||